1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal Trade Commission. February 4, 2026. Accessed February 5, 2026.
The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.
FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results